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Monosodium mate (MSU) crystals stimulate the metabolism of arachidonic acid in mixed populations of 
human leukocytes. Leukocytes exposed to MSU crystals released leukotriene Cd. Leukotriene C4 (LTC4) 
was characterized and detected by high-performance liquid chromatography (HPLC), UV absorption, 
bioassay with guinea pig ileum, and radioimmunoassay. Results indicate that MSU crystals stimulate the 
transformation of arachidonic acid and the formation of leukotriene C4 in human leukocytes; an effect 
inhibited by colchicine. Moreover, they suggest that LTG may serve as a mediator of inflammation i  
crystal-associated diseases. 
Leukotriene Cd Monosodium urate crystal 
1. INTRODUCTION 
In acute gouty arthritis crystalline monosodium 
urate (MSU) deposits in joint tissues. When in- 
jected into the joints of experimental animals, 
MSU crystals provoke an acute inflammatory 
response suggesting that MSU crystals play a ma- 
jor role in the pathophysiology of gouty arthritis 
[ 1,2]. Studies [l] indicate that polymorphonuclear 
leukocytes are required for crystal-induced ar- 
thritis and suggest hat interactions between these 
cells and crystals are essential for initiating the in- 
flammatory response. Yet results of other in vivo 
studies, utilizing continuous recording techniques 
suggest that mediators derived from platelets, 
macrophages and possibly synovial lining cells may 
initiate MSU-induced inflammation [2]. 
Although the cellular events responsible for 
crystal-induced inflammation are not completely 
clear, results of several studies indicate that un- 
coated MSU crystals activate various cell types in 
vitro. For example, human neutrophils exposed to 
MSU release lysosomal enzymes and generate ac- 
Radioimmunoassay Human leukocyte 
tive oxygen species [3] and human platelets ex- 
posed to MSU release their dense body consti- 
tuents [4,5] before lysis of the cells. The nature of 
MSU crystal-induced activation and secretion in 
these cells is unclear. Recent studies indicate 
however, that crystal-induced secretion is not sole- 
ly caused by the well-appreciated membranolytic 
effect of the crystal [7], but that interactions be- 
tween crystals and membrane proteins may lead to 
activation of inflammatory cells before lysis [7]. 
Recently, we demonstrated that MSU crystals 
stimulate the production of arachidonic acid 
metabolites by human neutrophils and platelets in 
the absence of demonstrable release of the 
cytoplasmic enzyme (LDH) [8]. Briefly, 
neutrophils exposed to uncoated MSU crystals 
generate leukotriene B4 (LTBd), its non-enzymatic 
isomers, and the double dioxygenation product 
SS,12S-DHETE from endogenous ources of ara- 
chidonate. In addition to these products both 
5-HETE and the w-oxidation products of LTB4 
and 5S, 12S-DHETE were formed. Human 
platelets exposed to MSU released free arachi- 
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donate and products of both the cyclooxygenase 
and lipoxygenase pathways including throm- 
boxane and 12-HETE [S]. Authors in [9] found 
leukotriene B4 to be elevated in gouty effusions but 
not in synovial fluids of patients with either 
osteoarthritis or rheumatoid arthritis. Since 
arachidonate metabolites may serve as mediators 
of inflammation (review [lo]) these studies suggest 
that metabolites of arachidonate may serve as 
mediators in crystal-associated diseases. This 
report describes the identification of leukotriene 
C4 in suspensions of human leukocytes exposed to 
crystals of MSU. 
2. MATERIALS AND METHODS 
Arachidonic acid was purchased from Nu- 
Check, MN, Dextran T-500 was obtained from 
Pharmacia (Uppsala) and Lymphoprep from 
Nyegaard (Oslo). Uric acid was from Merck 
(Darmstadt). Ionophore A23 187 and colchicine 
were from Sigma (St. Louis, MO) each were 
dissolved in ethanol, stored at - 20°C and diluted 
in buffer immediately before use. HPLC equip- 
ment was from Waters Associates (Milford, MA 
- pump 60OOA, injector U6K) and from LDC, 
Laboratory Data Control (Riviera Beach, FL - 
UV-detector LDC-III). All solvents were of HPLC 
grade obtained from Rathburn Chemicals 
(Walkerburne). FPL 55712 was a gift from Fisons 
Pharmaceutical Division (Loughborough) and syn- 
thetic LTC4 was generously supplied by Dr F. Fitz- 
patrick of the Upjohn Company (Kalamazoo, MI). 
2.1. Preparation of monosodium urate crystals 
Crystals of monosodium urate were prepared as 
in [I 11. Fresh crystals (approx. lo-15 pm in 
length) were prepared before incubations with 
leukocytes and each preparation was examined 
with polarising microscopy for the presence of 
strongly negative birefringent crystals. The native 
crystals were not coated with proteins. 
2.2. Cell preparations and incubations 
Suspensions of human leukocytes (e.g., 
neutrophils, eosinophils, basophils) were prepared 
from the peripheral blood of healthy donors col- 
lected at the Karolinska Hospital. Leukocyte 
suspensions - 100 x lo6 cells/ml of phosphate- 
buffered saline containing 0.6 mM CaC12 and 
110 
1 .O mM MgC12 (pH 7.45) - were prepared as in 
[12]. Leukocyte suspensions (50 ml) were warmed 
to 37°C in a water bath with slow continuous shak- 
ing (-24 rpm) for 5 min. Crystals of MSU were 
suspended in buffer and then added to the incuba- 
tions at final concentrations of 1-4 mg/ml. In- 
cubations were stopped after 15 min by centrifuga- 
tion and addition of 80% ethanol to the 
supernatants. 
2.3. Isolation and purification 
The ethanol solutions from each incubation 
were filtered and evaporated to dryness directly 
following the incubations [ 13,141. Samples were 
purified as in [12]. Briefly, ethanol fractions from 
incubations were subjected to alkaline hydrolysis 
at pH 12 and then immediately purified on 
Amberlite XAD-8 (Rohm and Haas, Philadelphia, 
PA) and silicic acid chromatography (cc7, Mallinc- 
krodt). Samples were further purified on reverse 
phase HPLC using a Polygosil 0.60-10 Cl8 (10 x 
100 mm) column and acetonitrile/H20, 2:70, buf- 
fered to apparent pH 5.7 with ammonium hydrox- 
ide as a mobile phase (flow rate 1 ml/min). UV 
detector was set as 280 nm. 
2.4. Analytical methods 
UV spectra were obtained on a Hewlett-Packard 
8450A spectrophotometer. Bioassay was per- 
formed on isolated guinea pig ileum in a 7 ml 
cuvette with Tyrode’s buffer containing mepyr- 
amine maleate (10m6 M) and atropine sulfate 
( 10m6 M) as in [13]. Radioimmunoassay for LTG 
was performed as in [ 141. Here 1 -ml suspensions of 
cells were incubated with crystals for 15 min at 
37°C. Cells were treated with colchicine (10e5 M) 
for 1 h, 37°C before addition of MSU. Control 
incubations without MSU were included in each 
experiment. Incubations were stopped by rapid 
freezing of the samples at -70°C. After thawing 
samples were centrifuged (1400 x g) and assayed 
without further purification. 
3. RESULTS AND DISCUSSION 
Human leukocytes exposed to crystals of MSU 
(but not urate in solution) produced slow-reacting 
substance as determined by the contractile 
response of isolated guinea pig ileum (fig.1). The 
response to synthetic LTG on the same ileum is 
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Fig.1. Guinea pig ileum bioassay. The contractile 
response of freshly prepared guinea pig ileum [13] was 
measured with synthetic LTC4 and material derived 
from incubation of MSU crystals (2 mg/ml) with human 
leukocytes (100 x IO6 cells/ml; 50 ml) 15 min, 37’C 
following extraction [12]. MSU crystals added irectly to 
the ileum did not provoke contraction. The responses 
are representative of those obtained in three separate 
experiments. 
shown for purposes of comparison. The contrac- 
tions induced by both synthetic LTC4 and the 
substance derived from incubation of human 
leukocytes with MSU crystals were rapidly re- 
versed upon addition of FPL55712 (lo-’ M) an an- 
tagonist of SRS [ 131, When exogenous arachidonic 
acid was added to incubations cont~ning MSU 
crystals SRS production was increased several fold 
(table 1). 
The major component eluting in the HPLC 
system described in section 2.3 comigrated with 
synthetic LTC4. The UV spectrum was essentially 
Table 1 
Formation of LTC4 by leukocytes exposed to MSU 
crystals: effect of colchicine 
Incubation 
Cells (alone) 
Cells i MSU crystals 
Colchicine-treated cells + MSU 
Cells + MSU crystals + 
LTG (pmol/ml) 
0.8 
5.1 
2.3 
exogenous arachidonic acid 14.8 
Cells were exposed to MSU crystals (2 mg/mI, 15 min, 
37°C) or pretreated with colchicine (10/M, 37”C, 1 h) 
before exposure to crystals. Supernatants were assayed 
by RIA [14]. Results represent the mean of 2 separate 
experiments 
identical to that of synthetic LTC4, with a max- 
imum at 280 nm and shoulders at 270 and 292 
(fig.2). The more polar materials eluting after the 
solvent front did not show UV spectra indicative of 
the presence of conjugated triene moieties. Unlike 
ionophore A23 187, MSU crystals did not stimulate 
the formation of appreciable quantities of either 
II-frans-LTC4 [12] or LTD4 [15]. 
In view of the clinical efficacy of colchicine in 
the treatment of gouty arthritis [16], we have ex- 
amined the action of this drug on MSU-induced 
formation of LTC4 using a sensitive radioim- 
munoassay. Leukocytes incubated with colchicine 
(10 yM, 37”C, 1 h) then exposed to MSU showed 
an impaired ability to form LTC4 (table 1). A 
similar effect was noted when LTB4 and its o- 
oxidation products were examined [8]. The ratio of 
LTB4 to LTC4 formed by leukocytes exposed to 
MSU crystals was approximately 2 : 1. With respect 
LTC 
280 + 
I 1 
280 320 
nm 
I 
& 
20 
hifl 
0 
Fig.2. Reverse-phase HPLC chromatogram of products 
obtained following incubation of human leukocytes with 
MSU crystals (2 ng/ml), 15 min, 37°C. The incubation 
was stopped with ethanol and the lipids were purified by 
c~omato~aphy on Amberlite SAD-8 resin followed by 
CC-7 silicic acid, before HPLC. The polygosil 
Cls-column was eluted with acetonitrile/HzO (30 : 70, 
v/v), pH 5.7, 1 ml/min. The inset shows the UV 
spectrum of the product eluting in this system. 
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to LTG formation, MSU crystals proved to be ap- 
proximately 2-log order less potent [14] than 
ionophore A23187. Nevertheless, when compared 
to other particulate stimuli encountered in 
pathology, such as opsonized microbes [17], MSU 
crystals appeared to be of equal potency with 
respect o LTG formation. Since mixed leukocyte 
suspensions were used for these studies it is not 
possible to assign the principal cell type(s) respon- 
sible for the production of LTG upon exposure to 
crystals. 
These studies therefore indicate that MSU 
crystals stimulate the release of endogenous 
arachidonic acid and its subsequent ransforma- 
tion to LTG in human leukocytes. Moreover, they 
suggest hat LTC4, a potent SRS [lo] which con- 
stricts pulmonary airways and increases vascular 
permeability [ 18,191, may play a role in the 
pathophysiology associated with crystal-induced 
diseases. 
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